Sign in
Taking people in United StatesNo phase

Remote Lifestyle Coaching with Glucose Monitoring for Healthy Weight Gain in Pregnancy

Tests remote coaching with glucose monitoring in pregnant women with overweight or obesity.

Key facts

Who runs it
Arkansas Children's Hospital Research Institute
Where
Little Rock, United StatesSee the site
Trial code
Registry title
Continuous Glucose and E-Monitoring to Support Healthy Weight Gain in Pregnancies - The GEM Study
Status
Recruiting
People taking part
16 people, planned
Started
1 Mar 2025
Expected to end
30 Sept 2027
Type of study
Interventional
Treatments tested
  • Continuous Glucose and E-Monitoring to Support Healthy Weight Gain in Pregnancy
Record updated
9 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for pregnant women with overweight or obesity, expecting one baby, to test a remote lifestyle program with glucose monitoring.

Age
18 to 45 years
Sex
Women only
Disease stage
Pregnant, less than 20 weeks of gestation, singleton pregnancy, BMI of 25 - 40 kg/m-2
Earlier treatment
Must not take medicines known to influence fetal growth, such as thyroid hormone, glucocorticoids, insulin or oral hypoglycemic agents. Must not have conceived with assisted fertility treatments.

Main reasons for not taking part

  • Smoker
  • Existing medical conditions that pregnancy might make worse, such as diabetes, kidney failure, high blood pressure or cancer
  • Current mental health or eating disorder
  • Contraindication to exercise
  • Plans to move out of the state in the next 6 months

This trial only enrols pregnant participants. The registry sentence this rests on: pregnant women less than 20 weeks of gestation at time of screening

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • pregnant women less than 20 weeks of gestation at time of screening
  • 18-45 years of age
  • BMI of 25 - 40 kg/m-2
  • Expecting a singleton pregnancy
  • Smartphone and/or reliable internet access
  • Willing to be identifiable to other study participants in the study program

Who cannot take part

  • Contraindication to exercise (OB/GYN release is obtained prior to consent)
  • Medications during pregnancy known to influence fetal growth (e.g., thyroid hormone, glucocorticoids, insulin, oral hypoglycemic agents)
  • Preexisting medical conditions that might be exacerbated by pregnancy (e.g., diabetes mellitus, chronic renal failure, hypertension, malignancies, seizure disorder, lupus, drug or alcohol abuse, serious psychiatric disorders)
  • Current mental health or eating disorder
  • Smoker
  • Conceived with assisted fertility treatments
  • Plans to move out of the state in the next 6 months following screening

Other criteria

  • The formative phase (Phase I), classified as exempt by the institutional review board will seek participation from individuals meeting the following criteria:
  • Currently pregnant or pregnant within the past 36 months
  • Community partners with relevant perspectives to inform recruitment, adaptation approaches and feasibility of the phase 2 pilot trial; Clinical Trial (Phase 2)

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 45 years old?

This trial is currently available in United States.

  • Arkansas Children's Research Institute - Arkansas Children's Nutrition Center, University of Arkansas for Medical SciencesLittle Rock, United StatesContact: Elizabeth Hayes, Recruitment CoordinatorTaking people

About the trial

What the trial wants to find out

This single-arm pilot study will evaluate the feasibility and acceptability of a remotely delivered behavioral lifestyle intervention, adapted from the SmartMoms framework, to promote health gestational weight gain in pregnant women with overweight and obesity. Twelve to sixteen participants will receive weekly virtual motivational interview sessions with trained health coaches, review their daily weight data, step count, and continuous glucose monitoring data, and tailored guidance on physical activity and nutrition. Educational content will be delivered electronically, with peer support provided through a closed online group. A simulated (mock) control arm will be created post hoc from existing records for preliminary comparisons; all enrolled participants will receive the intervention.

The group in the trial

  • Remote Weight & Step Monitoring + CGMTreatment being tested

    Women will engage in the remote intervention resembling efforts used by the SmartMoms intervention, but adapted to the needs of Arkansas women while also wearing unblinded CGM devices providing insights to glycemic trends in response to lifestyle factors.

    Treatment: Continuous Glucose and E-Monitoring to Support Healthy Weight Gain in Pregnancy

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Continuous Glucose and E-Monitoring to Support Healthy Weight Gain in Pregnancies - The GEM Study
Plain-language title
Remote Lifestyle Coaching with Glucose Monitoring for Healthy Weight Gain in PregnancyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Criteria questions
Built from NCT06666257, who can take part
Record updated
9 October 2026